InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hayman Robert, Director. Director active across 1 company, notably Evolus, Inc.. Cumulatively, 7 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €192k. Activity tracked since 24 January 2022. The latest transaction was disclosed on 7 February 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hayman Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
6,464 shares0Common StockSEC:0001570562-24-000022:0
218 shares0Common StockSEC:0001570562-23-000090:0
8,293 shares0Common StockSEC:0001570562-23-000025:0
8,909 shares@ US$10.347147.9% of flowCommon StockSEC:0001570562-22-000136:0
Canonical exit: 8 Dec 2022 (T+90)
5,000 shares@ US$10.0526.1% of flowCommon StockSEC:0001570562-22-000135:0
Canonical exit: 6 Dec 2022 (T+90)
4,967 shares@ US$10.0526.0% of flowCommon StockSEC:0001570562-22-000132:0
Canonical exit: 6 Dec 2022 (T+90)
15,568 shares0Common StockSEC:0001570562-22-000047:0
7 of 7 declarations
About Hayman Robert
Robert Hayman is a Board Member at Evolus, Inc. In this role, he participates in the governance of the company and strategic decision-making. With experience in the healthcare sector, he brings valuable insights to board discussions. Evolus, Inc. focuses on developing aesthetic products.
